Compounds and methods of use for treatment of neurogenic inflammation
US6291501A · kind A · utility
2Cited by
5References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 19, 1999 |
| Grant date | Sep 18, 2001 |
| Priority date | — |
| Expiry date | Feb 19, 2019 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The subject invention pertains to compounds which are useful as antiinflammatory agents and to compositions containing such compounds as active ingredients. The novel uses of the compounds relate to the anti-neurogenic inflammatory properties of the disclosed bis-heterocyclic compounds. Specifically exemplified herein are dragmacidin f, topsentin d, and topsentin e, and their salts, analogs, and derivatives.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.